Kilander, Helena
Weinryb, Maja
Vikström, Malin
Petersson, Kerstin
Larsson, Elin C.
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 25 May 2021
Accepted: 13 April 2022
First Online: 26 April 2022
Declarations
:
: This study was conducted in keeping with principles for research ethics according to the Helsinki Declaration, including written informed consent by all participants and protection of the integrity and dignity of individuals [CitationRef removed]. It includes no individual data from identifiable patients, only aggregate data from the SPR. The study was approved by the Regional Ethical Review Committee in Stockholm Sweden. The reference number is 2017/1312–31/5 and an additional application reference number for this study is 2108/1241–32.
: Not applicable.
: One of the co-authors (H Kilander) has been reimbursed by Merck Sharpe & Dohme Bayer AB, Sweden and Campus Pharma AB, Sweden for running educational programmes and giving lectures. The other co-authors (M Weinryb, M Vikström, K Petersson, EC Larsson) have stated that they have no conflicts of interest in connection with this manuscript.